Expertise in
4
conditions

Xingwu W. Ran

Chengdu, CN 
Expertise in
4
conditions
Chengdu, CN 
OverviewLocationsClinical Research

Overview

Xingwu Ran practices in Chengdu, China. Ran is highly rated in 4 conditions, according to our data. Their top areas of expertise are Type 2 Diabetes (T2D), Glucagonoma, Gangrene, Calciphylaxis, and Leg or Foot Amputation.

Their clinical research consists of co-authoring 121 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Locations

Chengdu, 610041, China
Other Locations
610041, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Parallel-Design, Open-Label, Randomized Control Study to Evaluate the Efficacy and Safety of LY3209590 as a Weekly Basal Insulin Compared to Insulin Degludec in Insulin Naïve Adults With Type 2 Diabetes
A Phase 3, Parallel-Design, Open-Label, Randomized Control Study to Evaluate the Efficacy and Safety of LY3209590 as a Weekly Basal Insulin Compared to Insulin Degludec in Insulin Naïve Adults With Type 2 Diabetes
Enrollment Status: Completed
Publish Date: May 16, 2025
Intervention Type: Drug
Study Phase: Phase 3
The Study to Investigate the Contribution of Basal and Post-prandial Blood Glucose to Overall Glycaemia in Subjects With Normal Glycaemic Metabolism and Type 2 Diabetes
The Study to Investigate the Contribution of Basal and Post-prandial Blood Glucose to Overall Glycaemia in Subjects With Normal Glycaemic Metabolism and Type 2 Diabetes
Enrollment Status: Completed
Publish Date: February 11, 2020
View 1 Less Clinical Trial

121 Total Publications

The Triglyceride Glucose-Conicity Index as a Novel Predictor for Stroke Risk: A Nationwide Prospective Cohort Study.
The Triglyceride Glucose-Conicity Index as a Novel Predictor for Stroke Risk: A Nationwide Prospective Cohort Study.
Journal: Journal of clinical medicine
Published: July 25, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ran's expertise for a condition
ConditionClose
      View All 27 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile